Health Care/Hospital

Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program

FRAMINGHAM, Mass., Dec. 17, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Sequencing Service Provider Program.  Complete Genomics'...

2024-12-17 22:00 802

Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary

Agreement to Deliver Critical Medicines  ITASCA, Ill., Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on theAsia-Pacific market is pleased to announce that Hupan Phar...

2024-12-17 21:30 1416

Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024

BEIJING, Dec. 17, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China's brands favored by foreigners in 2024 at the 2024 China Brand Day gala held i...

2024-12-17 20:40 1798

CTF Life Named Kai Tak Sports Park's Exclusive Founding Insurance Partner

Launching Community Fencing Programme to Nurture Future World-class Fencers  HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Chow Tai Fook Life Insurance Company Limited (CTF Life) has become the exclusive Founding Insurance Partner of Kai Tak Sports Park (KTSP), forming strategic partnership to foster ...

2024-12-17 18:23 1949

DPC Dash - Domino's Pizza China Wins Seven-Star Award for Outstanding Contributions in Food Safety & Public Health for the Fourth Year

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), the exclusive master franchisee for Domino's Pizza in the China Mainland, the Hong Kong Special Administrative Region ofChina , and the Macau Special Administrative Region ofChina, rec...

2024-12-17 17:57 1680

Fangzhou Inc. Recognized as an "Outstanding Enterprise in Digital Intelligence" by Analysys Star

HANGZHOU, China, Dec. 17, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was recognized as an "Outstanding Enterprise in Digital Intelligence" on the "Analysys Star 2024 Annual Award List" (releasedDecember 10th), alongside ...

2024-12-17 17:26 1023

Great Bay Bio Completes First Close of Series B Financing

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B financing round. This milestone was achieved with the round led by a syndication of a well-known strategic investment institution and its affiliate, Tiger Jade Pebble A...

2024-12-17 16:42 1140

GSK Leads Global Forum in Bangkok to Address Respiratory Health Challenges

GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok, Thailand. The event brought together renowned international speakers and healthcare professionals from 17 countries to address pressing global challenges in respiratory diseases, focusing on innovative solutions and ...

2024-12-17 11:59 1603

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis

SHANGHAI, Dec. 17, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the National Medical Products Ad...

2024-12-17 11:48 1891

Becoming a Data-Driven Healthcare Organisation: Info-Tech Releases New Blueprint for Maximising Data Insights in a Complex Environment

As healthcare organisations confront the complexities of managing vast amounts of data, Info-Tech Research Group has published a blueprint providing IT leaders with essential strategies to overcome challenges such as data silos, compliance mandates, and cybersecurity risks. The comprehensive reso...

2024-12-17 09:59 865

Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®

REHOVOT, Israel, Dec. 17, 2024 /PRNewswire/ -- Amai Proteins , a scale-up designer of novel proteins that answer the needs of consumers and industry, has succesfullly completed world's first double-blind, random clinical trial on the effects of their ...

2024-12-17 09:00 1006

SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals

SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder platform designed to selectively target tumor cells SK Biopharmaceuticals eyes innovative small protein-based radiopharmaceuticals on safety and ef...

2024-12-17 08:20 1108

Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index

* Acknowledged for strong environmental, social, and governance (ESG) performance and continued commitment to sustainability through net-zero initiatives and responsible value chain management INCHEON, South Korea, Dec. 16, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contr...

2024-12-17 07:51 1213

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

CUPERTINO, Calif., Dec. 16, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-small cell lung cancer (NSCLC). The trial showed a threefold increase in the object...

2024-12-17 02:05 1029

DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?

If your implant/replacement involved Exactech products – including Optetrak, Optetrak Logic, Truliant, Vantage, Connexion GXL, and Equinoxe – your attention to this notice is important.  NEW YORK, Dec. 17, 2024 /PRNewswire/ -- The following is being issued by Kroll Restructuring Administration L...

2024-12-17 00:13 1052

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p<0.0001) – Approximately 50% of patients in BROADWAY (Obicetrapib monotherapy) and  over 70% of patients in TANDEM (Fixed Do...

2024-12-16 22:08 1496

World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets

KOTA KINABALU, Malaysia, Dec. 16, 2024 /PRNewswire/ -- A groundbreaking new book by Professor Dr.Mike Chan, "STEM CELLS, PEPTIDES & IMMUNOTHERAPY: Handbook on Regenerative Medicine for Animals," introduces revolutionary ...

2024-12-16 22:00 2165

Everise Expands and Diversifies Its Healthcare Services Portfolio With the Acquisition of Continuum Global Solutions' Vertical

The acquisition strengthens Everise's position as a leading end-to-end healthcare experience provider PLANTATION, Fla., Dec. 16, 2024 /PRNewswire/ -- Everise, a global healthcare customer experience leader, today announced the successful completion of its acquisition of customer experience manag...

2024-12-16 21:00 2693

Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers

CAMBRIDGE, Mass., Dec. 16, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM ), today announced a research collaboration and license agreement to discover next-generation T-cell engagers ("TCEs") with Candid Therapeutics, ...

2024-12-16 20:03 859

Perennial General Hospital Tianjin, China's First Wholly Foreign-Owned Private Tertiary General Hospital Will Soon Commence Operations

SINGAPORE, Dec. 16, 2024 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") is pleased to announce that Perennial General Hospital in Tianjin city ("Perennial General Hospital Tianjin"), China, has become the country's first wholly foreign-owned private tertiary general hos...

2024-12-16 19:37 2194
1234567 ... 855